Success Story: Dual NIW & EB1A Success For An Associate Research Scholar From Iran Thanks To Our Expert Team’s Guidance

Posted by wegreened on January 30, 2026 in Biology (Pathology and Immunology, Human Genetics, Genomics, Molecular Biology, Animal, Plant, Microbiology, Genetics, Botany), EB1 Green Card, NIW

Client’s Testimonial:

“Thank you very much for your message and for all your help throughout my case.”

On April 2^nd, 2025, and October 20^th, 2025, we received another I-140 NIW (National Interest Waiver) and EB1A (Alien of Extraordinary Ability) Approvals for an Associate Research Scholar in the Field of Molecular Genetics (Approval Notice).

General Field: Molecular Genetics

Position at the Time of Case Filing: Associate Research Scholar

Country of Origin: Iran

State of Residence at the Time of Filing: Oklahoma

Approval Notice Date: April 2^nd, 2025 & October 20^th, 2025 (NIW&EB1A)

Processing Time: 4 months, 27 days (NIW), and 19 days (EB1A) (Premium Processing Requested for EB1A)

Case Summary:

NAILG successfully secured both EB1A (Alien of Extraordinary Ability) and NIW (National Interest Waiver) approvals for a molecular genetics expert whose work in cancer epigenetics and noncoding ribonucleic acids (ncRNA) has advanced understanding of tumor progression and potential therapeutic targets. Her pioneering research has provided key insights into the regulatory role of long ncRNA (lncRNA) in glioblastoma, contributing to the development of molecularly guided treatments for aggressive cancers.

Advancing Cancer Epigenetics and Therapeutic Innovation
With a Ph.D. in biology–molecular genetics, the client has focused on elucidating how ncRNA molecules regulate gene expression and drive oncogenic behavior in brain tumors. Her findings on the oncogenic role of the lncRNA MIAT have offered new directions for the development of RNA-based diagnostics and therapies, supporting precision oncology and improving clinical outcomes for cancer patients. Her ongoing research continues to bridge molecular biology and translational medicine, ensuring that laboratory discoveries can be translated into meaningful healthcare advancements.

Academic Record and Global Recognition
The petition presented a distinguished research record with 29 peer-reviewed journal articles (including 7 first-authored), 3 abstracts, and 1 first-authored book chapter, collectively cited 530 times by peers across the world. In addition, she has conducted at least 49 expert reviews, underscoring her recognized standing in the scientific community. These achievements reflect her sustained influence and international reputation as a thought leader in molecular oncology.

Expert Testimony Supporting Impact
Independent experts in the field highlighted the originality and value of her work, particularly its translational relevance to developing targeted therapies. One recommender stated:

“With this extensive research background, [Client] is poised to succeed in her efforts to advance her field and healthcare innovation in the United States.”

Approval and Outlook
Both petitions, filed under EB1A (premium processed) and NIW, were approved, demonstrating USCIS’s recognition of the client’s extraordinary ability and the national importance of her work. With NAILG’s support, her petitions successfully established her as a leader in cancer epigenetics whose continued contributions will strengthen the United States’ position in biomedical innovation and oncology research.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%